SISCAPA Assay Technologies Waters, SISCAPA Assay Technologies Develop Mass Spec Test for SARS-CoV-2 Premium The companies said that they envisioned the test, which is currently RUO, as potentially part of a mass spectrometry-based respiratory virus panel. The Decade in Proteomics: Most Significant New Instrumentation Premium Highlights included mass spec-focused developments like data-independent acquisition and ion mobility along with platforms including Thermo Fisher's Q Exactive. Plasma Proteomics Seeing Renewed Interest as Mass Spec Technology Advances Premium While the approach lost some of its luster after failing to deliver on early hype, technological improvements are revitalizing interest among researchers. Studies Suggest Challenges Remain for Dried Blood Spot Protein Assays Premium Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain. Waters Licenses Mass Spec Standardization Tech From SISCAPA Waters has obtained a non-exclusive license to the technology, which allows researchers to create internal standard calibration curves for their assays. Feb 10, 2017 Turnkey Clinical Mass Spec Solution on Horizon, Industry Analyst Suggests Premium Jul 21, 2016 SAT Developing Longitudinal Protein Panel Using Mass Spec, Dried Blood Spots Premium Jan 15, 2016 Emerging Proteomic Technologies: MALDI-TOF for Clinical Protein Quantitation Premium Oct 2, 2015 Sciex Moves to Develop Protein Quant Content With Fred Hutch-CPTAC Immuno-MRM Deal Premium Jul 23, 2015 SISCAPA Assay Technologies Taking Aim at Clinical Market Premium Nov 7, 2014 Precision Antibody Completes SBIR Contract to Generate Antibodies for SISCAPA Assays Premium Jun 11, 2014 New England Peptide, SISCAPA Collaborate on Peptide Standards May 27, 2014 Agilent, SAT Ink Pact to Provide Automated SISCAPA Workflows for Protein Quantitation May 16, 2014 SISCAPA Assay Technologies Closes Series A Funding Round Premium May 2, 2014 People in the News: Gustavo Salem, Michael Liang, Charles Wagner Premium Apr 11, 2014 New Products: SISCAPA, Mayo, Thermo Fisher, Waters Premium Mar 14, 2014 SISCAPA Assay Tech Exploring Dried Blood Spot Sampling for Mail-in, Longitudinal Proteomic Testing Premium Mar 14, 2014 People in the News: Selena Larkin Premium Mar 7, 2014 At MSACL 2014, Advances in MS-based Clinical Proteomics Draws Increased Scrutiny of Field's Methods Premium Sep 16, 2013 Bruker, SAT Ink Deal to Continue Collaboration on SISCAPA-MALDI Protein Assays Aug 2, 2013 New Study Further Bolsters Case for Bruker's MALDI Biotyper as Broad Clinical Proteomics Platform Premium Mar 15, 2013 Driven by Potential Cost Savings, Convenience, Proteomics Explores Dried Blood Spot Analysis Premium Jan 11, 2013 At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases Premium Jan 4, 2013 LBNL Researchers Launch Firm to Commercialize Multinozzle Emitter Technology for Nanoflow-ESI-MS Premium Jan 4, 2013 People in the News: Additions to SISCAPA Assay Technologies and More Premium Load More Breaking News Ceres Nanosciences Wins $1.4M in NIH RADx Funding for Additional Wastewater Epidemiology Centers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer GenomeWeb Top 40 up 8 Percent in November, Outpacing Broader Market Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio The Scan New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability. Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances. New mRNA Vaccines Offer Hope for Fighting Malaria A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines. Unique Germline Variants Found Among Black Prostate Cancer Patients Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.